Correlation Between Esperion Therapeutics and HUTCHMED DRC

Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Esperion Therapeutics and HUTCHMED DRC, you can compare the effects of market volatilities on Esperion Therapeutics and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and HUTCHMED DRC.

Diversification Opportunities for Esperion Therapeutics and HUTCHMED DRC

0.07

Correlation Coefficient

Esperion Therapeutics  HUTCHMED DRC

Significant diversification

The 3 months correlation between Esperion and HUTCHMED is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and HUTCHMED DRC go up and down completely randomly.

Pair Corralation between Esperion Therapeutics and HUTCHMED DRC

Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 1.4 times more return on investment than HUTCHMED DRC. However, Esperion Therapeutics is 1.4 times more volatile than HUTCHMED DRC. It trades about 0.16 of its potential returns per unit of risk. HUTCHMED DRC is currently generating about 0.0 per unit of risk. If you would invest  183.00  in Esperion Therapeutics on September 2, 2024 and sell it today you would earn a total of  97.00  from holding Esperion Therapeutics or generate 53.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Esperion Therapeutics  vs.  HUTCHMED DRC

Esperion Therapeutics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

HUTCHMED DRC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days HUTCHMED DRC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, HUTCHMED DRC is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Esperion Therapeutics and HUTCHMED DRC

The main advantage of trading using opposite Esperion Therapeutics and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.

The idea behind Esperion Therapeutics and HUTCHMED DRC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.